Raumedic has appointed Daniel Seibert as its new chief financial officer, which was effective on April 1. He succeeds Bernhard Kernen who left the company in March.
Seibert has 14 years of experience as a CFO at other medium-sized companies. He has worked in a number of industries, including the biotechnology and medical technology industries. Prior to joining Raumedic, Seibert was CFO at a high-tech surfaces and components company.
“Medical technology is very exciting. It offers a sphere of work that is very meaningful in the truest sense of the word since its clear mission is to enhance healthcare and quality of life,” Seibert said. “I also see great growth potential for the company and would like to do my bit in helping it tap that.”
As CFO, Seibert will be responsible for finance and organization at Raumedic. He will be responsible for the accounting, controlling, purchasing, IT, customer service and requirements and legal departments.
“We warmly welcome Mr. Seibert to the executive board and wish him every success in his new environment. His in-depth know-how will help us control important processes, and so the further development of Raumedic, even better.”
